Periostin secreted from CAF promotes cancer progression and drug resistance in non-small cell lung cancer

被引：0
|
作者：
Suzawa, Ken [1 ]
Tomida, Shuta [2 ]
Shien, Kazuhiko
Yamamoto, Hiromasa [1 ]
Toyooka, Shinichi [3 ]
机构：
[1] Okayama Univ, Dept Thorac Breast & Endocrinol Surg, Grad Sch, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Comprehens Genom Med, Okayama, Japan
[3] Okayama Univ, Grad Sch Med Dent Pharm Sci, Okayama, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1252
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [41] TERC promotes non-small cell lung cancer progression by facilitating the nuclear localization of TERT
    Sun, Haohui
    Li, Xiaodi
    Long, Qian
    Wang, Xiaonan
    Zhu, Wancui
    Chen, Enni
    Zhou, Wenhao
    Yang, Han
    Huang, Chuyang
    Deng, Wuguo
    Chen, Miao
    ISCIENCE, 2024, 27 (06)
  • [42] Cancer progression is mediated by proline catabolism in non-small cell lung cancer
    Liu, Yating
    Mao, Chao
    Wang, Min
    Liu, Na
    Ouyang, Lianlian
    Liu, Shouping
    Tang, Haosheng
    Cao, Ya
    Liu, Shuang
    Wang, Xiang
    Xiao, Desheng
    Chen, Ceshi
    Shi, Ying
    Yan, Qin
    Tao, Yongguang
    ONCOGENE, 2020, 39 (11) : 2358 - 2376
  • [43] Cancer progression is mediated by proline catabolism in non-small cell lung cancer
    Yating Liu
    Chao Mao
    Min Wang
    Na Liu
    Lianlian Ouyang
    Shouping Liu
    Haosheng Tang
    Ya Cao
    Shuang Liu
    Xiang Wang
    Desheng Xiao
    Ceshi Chen
    Ying Shi
    Qin Yan
    Yongguang Tao
    Oncogene, 2020, 39 : 2358 - 2376
  • [44] SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer
    Lu, Weidong
    Zuo, Yun
    Feng, Yufang
    Zhang, Min
    TUMOR BIOLOGY, 2014, 35 (11) : 10699 - 10705
  • [45] Are we Missing the Target? - Cancer Stem Cells and Drug Resistance in Non-small Cell Lung Cancer
    Gottschling, Sandra
    Schnabel, Philipp A.
    Herth, Felix J. F.
    Herpel, Esther
    CANCER GENOMICS & PROTEOMICS, 2012, 9 (05) : 275 - 286
  • [46] Drug Resistance to EGFR Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Soh, Junichi
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2014, 68 (04) : 191 - 200
  • [47] Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
    Wu, Jiajia
    Lin, Zhenghong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [48] Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
    Zhou, Kexun
    Li, Shuo
    Zhao, Yi
    Cheng, Ke
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
    Reactions Weekly, 2017, 1668 (1) : 192 - 192
  • [50] The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
    Yan, Tinghao
    Tian, Xinchen
    Liu, Fen
    Liu, Qingbin
    Sheng, Qing
    Wu, Jianlin
    Jiang, Shulong
    FRONTIERS IN ONCOLOGY, 2022, 12
12345